Editorial Commentary
Optimizing quadruplet therapy for older patients with newly diagnosed multiple myeloma: lessons from the REST trial
Annals of Blood
2026;
11:
10
.
(30 March 2026)
Editorial Commentary
Low dose radiation in indolent lymphoma: from dose optimization to biological insight
Annals of Blood
2026;
11:
9
.
(30 March 2026)
Editorial Commentary
Improved therapy for paroxysmal nocturnal hemoglobinuria
Annals of Blood
2026;
11:
8
.
(30 March 2026)
Editorial Commentary
Driving CAR-T therapy down the GPRC5D fast lane
Annals of Blood
2026;
11:
7
.
(30 March 2026)
Editorial Commentary
Ferritin-guided iron supplementation as a paradigm shift in blood donor care: advancing donor iron management through evidence-based supplementation
Annals of Blood
2026;
11:
6
.
(30 March 2026)
Case Report
Concurrent immune thrombocytopenia and amyotrophic lateral sclerosis with transient improvement in both conditions following efgartigimod: a case report
Annals of Blood
2026;
11:
5
.
(30 March 2026)
Case Report
Multiple crossmatch-incompatible red blood cell transfusions in a patient with anti-Yta (Cartwright) antibodies without hemolytic transfusion reactions: case report
Annals of Blood
2026;
11:
4
.
(30 March 2026)
Review Article
Plasma-derived medicinal products: a narrative review of the multi-layered approach to ensuring pathogen safety
Annals of Blood
2026;
11:
2
.
(30 March 2026)
Review Article
New developments and future trends of artificial blood
Annals of Blood
2026;
11:
1
.
(30 March 2026)
Review Article
The modern role of corticosteroids in immune thrombotic thrombocytopenic purpura
Annals of Blood
2025;
10:
26
.
(30 December 2025)
Review Article
A holistic view of international regulations and industry standards governing collection of plasma and manufacture of plasma-derived medicinal products
Annals of Blood
2025;
10:
25
.
(30 December 2025)
Review Article
The blood feud: compensated versus non-compensated source plasma donations
Annals of Blood
2025;
10:
24
.
(30 December 2025)
Review Article
A primer on pain in sickle cell disease: a literature review
Annals of Blood
2025;
10:
23
.
(30 December 2025)
Review Article
Source plasma apheresis and plasma-derived medicinal products: a historical review
Annals of Blood
2025;
10:
22
.
(30 December 2025)
Review Article
Missing for too long: a narrative review of what the sickle cell community can learn from patient registries in hemophilia and cystic fibrosis
Annals of Blood
2025;
10:
21
.
(30 December 2025)
Review Article
Transfusion with blood group genotype matching: advances, limitations, and challenges: a narrative review
Annals of Blood
2025;
10:
20
.
(30 December 2025)
Original Article
Mutational analysis of different epitopes in hepatitis B virus small surface protein among blood donors in Guangzhou, China: nonimmune epitope mutations as a nonnegligible factor
Annals of Blood
2025;
10:
19
.
(30 December 2025)
Original Article
Comparative study on the impact of different doses of plasma transfusion on coagulation function using an in vitro model
Annals of Blood
2025;
10:
18
.
(30 December 2025)
Original Article
Prevalence of preoperative anemia among adult patients and compliance to rational blood use in a tertiary hospital in a developing country: a cross-sectional study
Annals of Blood
2025;
10:
17
.
(30 December 2025)
Review Article
Current and future technologies for the production of plasma protein-derived medicines
Annals of Blood
2025;
10:
16
.
(30 September 2025)
Review Article
Patient blood management data and metrics—two key components
Annals of Blood
2025;
10:
15
.
(30 September 2025)
Review Article
Transfusion medicine informatics for neonatal and pediatric patients: a narrative review
Annals of Blood
2025;
10:
14
.
(30 September 2025)
Review Article
How do we solve the shortage of plasma derived medicines in low- and middle-income countries (LMIC)?
Annals of Blood
2025;
10:
13
.
(30 September 2025)
Review Article
Narrative review of patient blood management and transfusion for obstetric care
Annals of Blood
2025;
10:
12
.
(30 September 2025)